Skip to main content

Single Source Competition for Biostatistical and Coordinating Center Renewal of the NIDDK CLEAR Study Consortium (Closed-Loop and Education for Hypoglycemia Awareness Restoration) (U24- Resource-Related Research Project, Cooperative Agreements)

Agency: National Institutes of Health

Assistance Listings
  • 93.KT1 -- Diabetes, Digestive, Kidney Extramural Research - Special Diabetes Program
  • 93.KRC -- Diabetes, Digestive, Kidney Extramural Research - Research Centers

Forecasted opportunityLast Updated: Nov 18, 2026

Important dates

  • Forecasted post date: May 10, 2027
  • Forecasted application due date: June 10, 2027
  • Forecasted award date: March 1, 2028
  • Forecasted project start date: March 10, 2028
  • Fiscal Year: 2028

Award details

  • Expected project funding: $4,700,000
  • Expected awards: 1

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:RFA-DK-28-117
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: November 18, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

This NOFO invites a single source application for the continuation of the Biostatistics and Coordinating Center (BCC) at Pennsylvania State University-Hershey Medical Center during a 3-year continuation of the CLEAR (Closed Loop and Education for Hypglycemia Awareness Restoration) Study Consortium.  This BCC team has provided extensive logistical and statistical support for the CLEAR-Study Consortium since its inception in FY2022.  The continuation/ renewal of the CLEAR Study Consortium is for the period of January 2028-December 2030.  The BCC at Pennsylvania State University-Hershey Medical Center will continue to include a domestic sub-award to the JAEB Center for Health Research for digital device management.  A separate NOFO (RFA-DK28-118) will be utilized to invite 8 currently active clinical centers (CCs) to apply for a 3-year continuation.

The goal of the CLEAR Study Consortium remains to examine the ability of current technology, including continuous glucose monitoring coupled with automated insulin delivery (referred to as hybrid closed loop (HCL) systems), and advanced education on hypoglycemia avoidance to prevent recurrent hypoglycemia and, through that mechanism, restore awareness of hypoglycemia in patients with type 1 diabetes (T1D) with impaired awareness of hypoglycemia (IAH). 

The consortium is utilizing state of the art metabolic assessments such as hypoglycemic, hyperinsulinemic clamps for the measurement of CRRs in epinephrine and hypoglycemia symptom scores to identify restoration of awareness, examine heterogeneity in the ability to restore awareness of hypoglycemia, validate self-report assessments that are currently used to identify patients with IAH.

Eligibility

Education

  • Public and state institutions of higher education

Miscellaneous

  • Other

Additional information on eligibility

This is a forecast for a single source Notice of Funding Opportunity (NOFO) that will invite application(s) from eligible organizations to apply. The application will be peer-reviewed and only funded if meritorious.

Documents

No documents are currently available.

Agency contact information

Email: NIDDK_DEM@nih.gov

NIDDK_DEM@nih.gov

Division of Diabetes, Endocrinology and Metabolic Diseases Please contact via e-mail

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov